Literature DB >> 18987655

Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.

W Deenik, H B Beverloo, S C P A M van der Poel-van de Luytgaarde, M M Wattel, J W J van Esser, P J M Valk, J J Cornelissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18987655     DOI： 10.1038/leu.2008.318

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  25 in total

1.  NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.

Authors:  Nicolas Duployez; Guillaume Grzych; Benoît Ducourneau; Martin Alarcon Fuentes; Nathalie Grardel; Thomas Boyer; Wadih Abou Chahla; Bénédicte Bruno; Brigitte Nelken; Emmanuelle Clappier; Claude Preudhomme
Journal:  Haematologica       Date:  2015-12-17       Impact factor: 9.941

2.  Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.

Authors:  S Koschmieder; T Burmeister; M Brüggemann; A Berkemeier; S Volpert; P Wieacker; G Silling; N Gökbuget; C Müller-Tidow; W E Berdel; M Stelljes
Journal:  Leukemia       Date:  2013-09-19       Impact factor: 11.528

3.  Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

Authors:  Shannon L Maude; Sibasish Dolai; Cristina Delgado-Martin; Tiffaney Vincent; Alissa Robbins; Arthavan Selvanathan; Theresa Ryan; Junior Hall; Andrew C Wood; Sarah K Tasian; Stephen P Hunger; Mignon L Loh; Charles G Mullighan; Brent L Wood; Michelle L Hermiston; Stephan A Grupp; Richard B Lock; David T Teachey
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

4.  A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).

Authors:  Satu Mustjoki; Sari Hernesniemi; Auvo Rauhala; Marketta Kähkönen; Anders Almqvist; Tuija Lundán; Kimmo Porkka
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

5.  Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia.

Authors:  Jarno L Kivioja; Angeliki Thanasopoulou; Ashwini Kumar; Mika Kontro; Bhagwan Yadav; Muntasir M Majumder; Komal K Javarappa; Samuli Eldfors; Juerg Schwaller; Kimmo Porkka; Caroline A Heckman
Journal:  Leukemia       Date:  2018-12-19       Impact factor: 11.528

Review 6.  Relapsed T Cell ALL: Current Approaches and New Directions.

Authors:  Christine M McMahon; Selina M Luger
Journal:  Curr Hematol Malig Rep       Date:  2019-04       Impact factor: 3.952

Review 7.  Can one target T-cell ALL?

Authors:  Adolfo Ferrando
Journal:  Best Pract Res Clin Haematol       Date:  2018-10-17       Impact factor: 3.020

Review 8.  Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.

Authors:  Sarah K Tasian; Stephen P Hunger
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

9.  Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Authors:  Kathryn G Roberts; Ryan D Morin; Jinghui Zhang; Martin Hirst; Yongjun Zhao; Xiaoping Su; Shann-Ching Chen; Debbie Payne-Turner; Michelle L Churchman; Richard C Harvey; Xiang Chen; Corynn Kasap; Chunhua Yan; Jared Becksfort; Richard P Finney; David T Teachey; Shannon L Maude; Kane Tse; Richard Moore; Steven Jones; Karen Mungall; Inanc Birol; Michael N Edmonson; Ying Hu; Kenneth E Buetow; I-Ming Chen; William L Carroll; Lei Wei; Jing Ma; Maria Kleppe; Ross L Levine; Guillermo Garcia-Manero; Eric Larsen; Neil P Shah; Meenakshi Devidas; Gregory Reaman; Malcolm Smith; Steven W Paugh; William E Evans; Stephan A Grupp; Sima Jeha; Ching-Hon Pui; Daniela S Gerhard; James R Downing; Cheryl L Willman; Mignon Loh; Stephen P Hunger; Marco A Marra; Charles G Mullighan
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

10.  NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.

Authors:  Kim De Keersmaecker; Michaël Porcu; Luk Cox; Tiziana Girardi; Roel Vandepoel; Joyce Op de Beeck; Olga Gielen; Nicole Mentens; Keiryn L Bennett; Oliver Hantschel
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.